Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis
NCT ID: NCT00926328
Last Updated: 2013-08-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
120 participants
INTERVENTIONAL
2007-06-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A -Experimental toothpaste
triclosan/copolymer/fluoride toothpaste
Triclosan, fluoride
Six Month study, brush twice daily
B - control toothpaste
sodium fluoride only toothpaste (placebo)
Fluoride
twice daily usage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triclosan, fluoride
Six Month study, brush twice daily
Fluoride
twice daily usage
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health.
* Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
* Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
* Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
* Signed Informed Consent Form.
Exclusion Criteria
* Presence of partial removable dentures.
* Tumor(s) of the soft or hard tissues of the oral cavity.
* Advanced periodontal disease (purulent exudate,tooth mobility, and/or extensive loss of
* periodontal attachment or alveolar bone).
* Five or more carious lesions requiring immediate restorative treatment.
* Use of antibiotics any time during the one month prior to entry into the study.
* Participation in any other clinical study or test panel within the one month prior to entry
* into the study.
* Pregnant women or women who are breast feeding.
* Receive a dental prophylaxis in the past two weeks prior to baseline examinations.
* History of allergic to personal care/consumer products or their ingredients.
* Taking any prescription medicines. That might interfere with the study outcome.
* Individuals with an existing medical condition which prohibits them from not eating or drinking for periods up to 4 hours.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colgate Palmolive
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Augusto E Boneta, DDS
Role: PRINCIPAL_INVESTIGATOR
Dental Research Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Fernando Autran
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO-0507-PL-SP-CT-BS
Identifier Type: -
Identifier Source: org_study_id